A leader in advanced collagen biomaterials derived from jellyfish has closed an £8.7 million Series A equity financing round. Jellagen is looking to open up a broad range of possibilities for revolutionising regenerative medicine through medical devices and culture applications. Funding from major Welsh institutions and international investors will enable Jellagen to continue development of … Continue reading Jellyfish tech firm ‘to revolutionise regenerative medicine’